News

Video

Updated NCCN Guidelines for the Treatment of Advanced or Recurrent Endometrial Cancer

Key opinion leaders review recent updates to the NCCN guidelines for treating recurrent and advanced endometrial cancer, including biomarker testing and targeted therapies like dostarlimab and trastuzumab.

Related Videos
Kathleen N. Moore, MD, MS
5 KOLs are featured in this series.
5 KOLs are featured in this series.
5 KOLs are featured in this series.